Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04886349 · ClinicalTrials.gov registry record
Platelet-rich Plasma for Thumb Carpometacarpal Joint Osteoarthritis
A clinical trial of Thumb Carpometacarpal Joint Osteoarthritis, sponsored by Mayo Clinic.
- Completed
- Registry status
- 170
- Enrollment target
- 1
- Study location
NCT04886349: Completed study of Thumb Carpometacarpal Joint Osteoarthritis, sponsored by Mayo Clinic.
NCT04886349 is a study of Thumb Carpometacarpal Joint Osteoarthritis that has completed, run by Mayo Clinic. The registered enrollment target is 170 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04886349, a study of Thumb Carpometacarpal Joint Osteoarthritis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate a case series of patients treated with Platelet-rich plasma for thumb carpometacarpal joint osteoarthritis. Carpometacarpal arthritis is a highly prevalent condition with significant effects on quality of life and function. Meanwhile, platelet-rich plasma has been demonstrated to be an effective treatment for various musculoskeletal conditions.
Primary Outcome
Subjective patient satisfaction on a 1-5 point scale with 1 being the worst, 5 being the best. Obtained via follow-up interview.
Conditions Studied
Interventions
- BIOLOGICAL Platelet-rich plasma
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-04-02 |
What the finished NCT04886349 record still lists
NCT04886349 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Thumb Carpometacarpal Joint Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Platelet-rich plasma is the first listed.
NCT04886349 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04886349 about?
NCT04886349 is a clinical study titled "Platelet-rich Plasma for Thumb Carpometacarpal Joint Osteoarthritis". The purpose of this study is to investigate a case series of patients treated with Platelet-rich plasma for thumb carpometacarpal joint osteoarthritis. Carpometacarpal arthritis is a highly prevalent condition with significant effects on quality of life and function. Meanwhile, platelet-rich plasma ...
What is the current status of trial NCT04886349?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2020-10-01. Estimated completion is 2021-04-02.
What conditions does trial NCT04886349 study?
This clinical trial studies the following conditions: Thumb Carpometacarpal Joint Osteoarthritis.
What interventions are being tested in trial NCT04886349?
The interventions under investigation include: Platelet-rich plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT04886349?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04886349 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI